Glioblastoma Clinical Trials in Baltimore, MD

Glioblastoma Clinical Trials in Baltimore, MD

View the best 10 glioblastoma medical studies in Baltimore, Maryland. Access promising new therapies by applying to a Baltimore-based Glioblastoma clinical trial.

Trials in Baltimore, Maryland

Here are the top 10 medical studies for glioblastoma in Baltimore, Maryland

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of Northwestern University in Chicago, United States.

Carboplatin

Chemotherapy

Recruiting2 awardsPhase 3
This trial tests a new method to treat recurrent brain cancer using an ultrasound device called SonoCloud-9. The device helps open the brain's protective barrier so that more of the chemotherapy drug carboplatin can reach the tumor. The goal is to see if this combination makes the treatment more effective. Carboplatin has been used in various studies for treating high-grade gliomas and glioblastomas, often showing modest efficacy due to low tissue concentration when delivered intravenously.
Image of Rady Children's Hospital in San Diego, United States.

Fimepinostat

Histone Deacetylase (HDAC) Inhibitor

Recruiting1 awardPhase < 1
This trial is testing how well fimepinostat works in treating patients with newly diagnosed brain tumors. Fimepinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of University of California San Francisco in San Francisco, United States.

TheraSphere GBM

Brachytherapy

Recruiting1 awardPhase < 1
This trial is testing a new radiation treatment using tiny radioactive beads for patients with aggressive brain cancer that has come back. The treatment aims to target the tumor more precisely and reduce side effects compared to standard treatments. GammaTile is a device that uses cesium-131 radiation-emitting seeds embedded in a collagen tile to provide targeted radiation therapy for brain tumors.
Image of University of California, San Diego Rady Children's Hospital in San Diego, United States.

Specialized tumor board recommendation

Molecular Profiling

Recruiting1 award9 criteria
This trial will test a new treatment approach for children with High-grade gliomas HGG that is based on each patient's tumor gene expression, whole-exome sequencing (WES), targeted panel profile (UCSF 500 gene panel), and RNA-Seq.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Image of National Institutes of Health Clinical Center in Bethesda, United States.

Nivolumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is studying the changes in immune cells in the blood of people with newly diagnosed GBM or gliosarcoma, who take ipilimumab and nivolumab, along with temozolomide.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of Children's Hospital Los Angeles in Los Angeles, United States.

APX005M

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor.
Image of Children's Hospital Colorado in Aurora, United States.

Everolimus +1 More

mTOR Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.